{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:12:11Z","timestamp":1761883931487,"version":"build-2065373602"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["001","001"],"award-info":[{"award-number":["001","001"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001","001"],"award-info":[{"award-number":["001","001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Secretaria Nacional de Pol\u00edticas sobre Drogas","award":["Edital n\u00b001, 26\/05\/2015"],"award-info":[{"award-number":["Edital n\u00b001, 26\/05\/2015"]}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/19011-9"],"award-info":[{"award-number":["2019\/19011-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-025-06946-0","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:01:03Z","timestamp":1761879663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl\/6 mice"],"prefix":"10.1007","author":[{"given":"V\u00edtor","family":"Bruno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00eddia Emmanuela Wiazowski","family":"Spelta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus Lujan","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiane","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Aparecida Passos Bismara","family":"Paranhos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana Pereira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maur\u00edcio","family":"Yonamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael Caio Tamborelli","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa Helena","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"de Pasquale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana","family":"Camarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Marcourakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"6946_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.brainresrev.2008.08.002","volume":"59","author":"MA Aguilar","year":"2009","unstructured":"Aguilar MA, Rodr\u00edguez-Arias M, Mi\u00f1arro J (2009) Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 59:253\u2013277. https:\/\/doi.org\/10.1016\/j.brainresrev.2008.08.002","journal-title":"Brain Res Rev"},{"key":"6946_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113546","volume":"416","author":"CAF Almeida","year":"2022","unstructured":"Almeida CAF, Pereira-Junior AA, Rangel JG et al (2022) Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice. Behav Brain Res 416:113546. https:\/\/doi.org\/10.1016\/j.bbr.2021.113546","journal-title":"Behav Brain Res"},{"key":"6946_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00136","volume":"9","author":"PCR Barbosa","year":"2018","unstructured":"Barbosa PCR, T\u00f3foli LF, Bogenschutz MP et al (2018) Assessment of alcohol and tobacco use disorders among religious users of Ayahuasca. Front Psychiatry 9:136. https:\/\/doi.org\/10.3389\/fpsyt.2018.00136","journal-title":"Front Psychiatry"},{"key":"6946_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ph13110334","volume":"13","author":"AM Brito-da-Costa","year":"2020","unstructured":"Brito-da-Costa AM, Dias-da-Silva D, Gomes NGM et al (2020) Toxicokinetics and toxicodynamics of Ayahuasca alkaloids N,N-dimethyltryptamine (DMT), Harmine, harmaline and tetrahydroharmine: clinical and forensic impact. Pharmaceuticals (Basel) 13:334. https:\/\/doi.org\/10.3390\/ph13110334","journal-title":"Pharmaceuticals (Basel)"},{"key":"6946_CR5","doi-asserted-by":"publisher","unstructured":"Bruno V, L\u00f3pez-Canul M, Richardson B et al (2025) High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats. J Psychopharmacol 02698811251368361. https:\/\/doi.org\/10.1177\/02698811251368361","DOI":"10.1177\/02698811251368361"},{"key":"6946_CR6","first-page":"40","volume":"28","author":"V Bruno","year":"2022","unstructured":"Bruno V, Wiazowski Spelta LE, Dur\u00e3o AC et al (2022) Psychedelics and mental health: an alternative strategy to treat mental impairments triggered or aggravated by COVID-19. Altern Ther Health Med 28:40\u201343","journal-title":"Altern Ther Health Med"},{"key":"6946_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/02791072.2005.10399796","volume":"37","author":"JC Callaway","year":"2005","unstructured":"Callaway JC (2005) Various alkaloid profiles in decoctions of banisteriopsis Caapi. J Psychoact Drugs 37:151\u2013155. https:\/\/doi.org\/10.1080\/02791072.2005.10399796","journal-title":"J Psychoact Drugs"},{"key":"6946_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/dev.21089","volume":"56","author":"PF Carrara-Nascimento","year":"2014","unstructured":"Carrara-Nascimento PF, Olive MF, Camarini R (2014) Ethanol pre-exposure during adolescence or adulthood increases ethanol intake but ethanol-induced conditioned place preference is enhanced only when pre-exposure occurs in adolescence. Dev Psychobiol 56:36\u201348. https:\/\/doi.org\/10.1002\/dev.21089","journal-title":"Dev Psychobiol"},{"key":"6946_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00561","volume":"9","author":"EG Cata-Preta","year":"2018","unstructured":"Cata-Preta EG, Serra YA, Moreira-Junior EDC et al (2018) Ayahuasca and its DMT- and \u03b2-carbolines \u2013 containing ingredients block the expression of ethanol-induced conditioned place preference in mice: role of the treatment environment. Front Pharmacol 9:561. https:\/\/doi.org\/10.3389\/fphar.2018.00561","journal-title":"Front Pharmacol"},{"key":"6946_CR10","doi-asserted-by":"publisher","unstructured":"Choi C, Johnson DE, Chen-Li D, Rosenblat J (2024) Mechanisms of psilocybin on the treatment of posttraumatic stress disorder. J Psychopharmacol 02698811241286771. https:\/\/doi.org\/10.1177\/02698811241286771","DOI":"10.1177\/02698811241286771"},{"key":"6946_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.04.015","volume":"493","author":"MB Cont\u00f3","year":"2022","unstructured":"Cont\u00f3 MB, Pautassi RM, Camarini R (2022) Rewarding and antidepressant properties of ketamine and ethanol: effects on the brain-derived neurotrophic factor and TrkB and p75NTR receptors. Neuroscience 493:1\u201314. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.04.015","journal-title":"Neuroscience"},{"key":"6946_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/02791072.2018.1447174","volume":"50","author":"JI Cruz","year":"2018","unstructured":"Cruz JI, Nappo SA (2018) Is ayahuasca an option for the treatment of crack cocaine dependence? J Psychoactive Drugs 50:247\u2013255. https:\/\/doi.org\/10.1080\/02791072.2018.1447174","journal-title":"J Psychoactive Drugs"},{"key":"6946_CR13","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/nprot.2006.279","volume":"1","author":"CL Cunningham","year":"2006","unstructured":"Cunningham CL, Gremel CM, Groblewski PA (2006) Drug-induced conditioned place preference and aversion in mice. Nat Protoc 1:1662\u20131670. https:\/\/doi.org\/10.1038\/nprot.2006.279","journal-title":"Nat Protoc"},{"key":"6946_CR14","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00213-022-06063-2","volume":"239","author":"D Daldegan-Bueno","year":"2022","unstructured":"Daldegan-Bueno D, Maia LO, Massarentti CM, T\u00f3foli LF (2022) Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil. Psychopharmacology 239:1767\u20131782. https:\/\/doi.org\/10.1007\/s00213-022-06063-2","journal-title":"Psychopharmacology"},{"key":"6946_CR15","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","volume":"235","author":"AL Danforth","year":"2018","unstructured":"Danforth AL, Grob CS, Struble C et al (2018) Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235:3137\u20133148. https:\/\/doi.org\/10.1007\/s00213-018-5010-9","journal-title":"Psychopharmacology"},{"key":"6946_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25092072","volume":"25","author":"G de Oliveira Silveira","year":"2020","unstructured":"de Oliveira Silveira G, Guimar\u00e3es Dos Santos R, Rebello Louren\u00e7o F et al (2020) Stability evaluation of DMT and Harmala alkaloids in Ayahuasca tea samples. Molecules 25:2072. https:\/\/doi.org\/10.3390\/molecules25092072","journal-title":"Molecules"},{"key":"6946_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","volume":"126","author":"E Dom\u00ednguez-Clav\u00e9","year":"2016","unstructured":"Dom\u00ednguez-Clav\u00e9 E, Soler J, Elices M et al (2016) Ayahuasca: pharmacology, neuroscience and therapeutic potential. Brain Res Bull 126:89\u2013101. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.03.002","journal-title":"Brain Res Bull"},{"key":"6946_CR18","doi-asserted-by":"publisher","unstructured":"Dos Santos RG, Hallak JEC (2024) Ayahuasca: pharmacology, safety, and therapeutic effects. CNS Spectr 1\u20139. https:\/\/doi.org\/10.1017\/S109285292400213X","DOI":"10.1017\/S109285292400213X"},{"key":"6946_CR19","doi-asserted-by":"crossref","unstructured":"DuPont CM, Johnson MW (2025) Chapter Ten - Psychedelics and substance use disorder treatment. In: Nutt DJ, Thurgur H (eds)\u00a0Int. Rev. Neurobiol.. Academic Press, pp 305\u2013327","DOI":"10.1016\/bs.irn.2025.03.005"},{"key":"6946_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13659-019-0210-5","volume":"9","author":"EA Estrella-Parra","year":"2019","unstructured":"Estrella-Parra EA, Almanza-P\u00e9rez JC, Alarc\u00f3n-Aguilar FJ (2019) Ayahuasca: uses, phytochemical and biological activities. Nat Prod Bioprospect 9:251\u2013265. https:\/\/doi.org\/10.1007\/s13659-019-0210-5","journal-title":"Nat Prod Bioprospect"},{"key":"6946_CR21","volume-title":"European drug report 2025: trends and developments","author":"EUDA","year":"2025","unstructured":"EUDA (2025) European drug report 2025: trends and developments. European Union Drugs Agency (EUDA), Lisbon, Portugal"},{"key":"6946_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200403000-00007","volume":"15","author":"WE Fantegrossi","year":"2004","unstructured":"Fantegrossi WE, Woods JH, Winger G (2004) Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. Behav Pharmacol 15:149","journal-title":"Behav Pharmacol"},{"key":"6946_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114865","volume":"285","author":"B Gianfratti","year":"2022","unstructured":"Gianfratti B, Tabach R, Sakalem ME (2022) Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity. J Ethnopharmacol 285:114865. https:\/\/doi.org\/10.1016\/j.jep.2021.114865","journal-title":"J Ethnopharmacol"},{"key":"6946_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.739012","volume":"12","author":"GM Henriques","year":"2021","unstructured":"Henriques GM, Anjos-Santos A, Rodrigues IRS et al (2021) Ibogaine blocks cue- and drug-induced reinstatement of conditioned place preference to ethanol in male mice. Front Pharmacol 12:739012. https:\/\/doi.org\/10.3389\/fphar.2021.739012","journal-title":"Front Pharmacol"},{"key":"6946_CR25","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","volume":"162","author":"PW Kalivas","year":"2005","unstructured":"Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. AJP 162:1403\u20131413. https:\/\/doi.org\/10.1176\/appi.ajp.162.8.1403","journal-title":"AJP"},{"key":"6946_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax1532","volume":"5","author":"KM Kampman","year":"2019","unstructured":"Kampman KM (2019) The treatment of cocaine use disorder. Sci Adv 5:eaax1532. https:\/\/doi.org\/10.1126\/sciadv.aax1532","journal-title":"Sci Adv"},{"key":"6946_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00213-003-1441-y","volume":"168","author":"JL Katz","year":"2003","unstructured":"Katz JL, Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology 168:21\u201330. https:\/\/doi.org\/10.1007\/s00213-003-1441-y","journal-title":"Psychopharmacology"},{"key":"6946_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/16066359.2020.1724972","volume":"29","author":"M Klein","year":"2021","unstructured":"Klein M (2021) Relapse into opiate and crack cocaine misuse: a scoping review. Addict Res Theory 29:129\u2013147. https:\/\/doi.org\/10.1080\/16066359.2020.1724972","journal-title":"Addict Res Theory"},{"key":"6946_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3:760\u2013773. https:\/\/doi.org\/10.1016\/S2215-0366(16)00104-8","journal-title":"Lancet Psychiatry"},{"key":"6946_CR30","unstructured":"Kumar S, Mithoefer M, Mojeiko V, Doblin R (2023) Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma. clinicaltrials.gov"},{"key":"6946_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/7854_2012_202","volume":"13","author":"R Martin-Fardon","year":"2013","unstructured":"Martin-Fardon R, Weiss F (2013) Modeling relapse in animals. Curr Top Behav Neurosci 13:403\u2013432. https:\/\/doi.org\/10.1007\/7854_2012_202","journal-title":"Curr Top Behav Neurosci"},{"key":"6946_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2020.00075","volume":"14","author":"G McKendrick","year":"2020","unstructured":"McKendrick G, Garrett H, Jones HE et al (2020) Ketamine blocks morphine-induced conditioned place preference and anxiety-like behaviors in mice. Front Behav Neurosci 14:75. https:\/\/doi.org\/10.3389\/fnbeh.2020.00075","journal-title":"Front Behav Neurosci"},{"key":"6946_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2020.582147","volume":"14","author":"G McKendrick","year":"2020","unstructured":"McKendrick G, Graziane NM (2020) Drug-induced conditioned place preference and its practical use in substance use disorder research. Front Behav Neurosci 14:582147. https:\/\/doi.org\/10.3389\/fnbeh.2020.582147","journal-title":"Front Behav Neurosci"},{"key":"6946_CR34","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.124.002237","author":"CE Miller","year":"2024","unstructured":"Miller CE, Zoladz PR (2024) Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder. J Pharmacol Exp Ther. https:\/\/doi.org\/10.1124\/jpet.124.002237","journal-title":"J Pharmacol Exp Ther"},{"key":"6946_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","volume":"258","author":"S Muttoni","year":"2019","unstructured":"Muttoni S, Ardissino M, John C (2019) Classical psychedelics for the treatment of depression and anxiety: a systematic review. J Affect Disord 258:11\u201324. https:\/\/doi.org\/10.1016\/j.jad.2019.07.076","journal-title":"J Affect Disord"},{"key":"6946_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.physbeh.2015.01.032","volume":"142","author":"AJ Oliveira-Lima","year":"2015","unstructured":"Oliveira-Lima AJ, Santos R, Hollais AW et al (2015) Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice. Physiol Behav 142:28\u201336. https:\/\/doi.org\/10.1016\/j.physbeh.2015.01.032","journal-title":"Physiol Behav"},{"key":"6946_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","volume":"49","author":"F Palhano-Fontes","year":"2019","unstructured":"Palhano-Fontes F, Barreto D, Onias H et al (2019) Rapid antidepressant effects of the psychedelic Ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 49:655\u2013663. https:\/\/doi.org\/10.1017\/S0033291718001356","journal-title":"Psychol Med"},{"key":"6946_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/7854_2021_277","volume":"56","author":"F Palhano-Fontes","year":"2022","unstructured":"Palhano-Fontes F, Soares BL, Galv\u00e3o-Coelho NL et al (2022) Ayahuasca for the treatment of depression. Curr Top Behav Neurosci 56:113\u2013124. https:\/\/doi.org\/10.1007\/7854_2021_277","journal-title":"Curr Top Behav Neurosci"},{"key":"6946_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1548-6","volume":"16","author":"AR Pasareanu","year":"2016","unstructured":"Pasareanu AR, Vederhus J-K, Opsal A (2016) Improved drug-use patterns at 6 months post-discharge from inpatient substance use disorder treatment: results from compulsorily and voluntarily admitted patients. BMC Health Serv Res 16:291. https:\/\/doi.org\/10.1186\/s12913-016-1548-6","journal-title":"BMC Health Serv Res"},{"key":"6946_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/dar.13348","volume":"41","author":"D Perkins","year":"2022","unstructured":"Perkins D, Opaleye ES, Simonova H et al (2022) Associations between Ayahuasca consumption in naturalistic settings and current alcohol and drug use: results of a large international cross-sectional survey. Drug Alcohol Rev 41:265\u2013274. https:\/\/doi.org\/10.1111\/dar.13348","journal-title":"Drug Alcohol Rev"},{"key":"6946_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/pca.1110","volume":"20","author":"APS Pires","year":"2009","unstructured":"Pires APS, De Oliveira CDR, Moura S et al (2009) Gas chromatographic analysis of dimethyltryptamine and \u03b2\u2010carboline alkaloids in ayahuasca, an amazonian psychoactive plant beverage. Phytochem Anal 20:149\u2013153. https:\/\/doi.org\/10.1002\/pca.1110","journal-title":"Phytochem Anal"},{"key":"6946_CR42","volume-title":"Methods of behavior analysis in neuroscience","author":"AJ Prus","year":"2009","unstructured":"Prus AJ, James JR, Rosecrans JA (2009) Conditioned place preference. In: Buccafusco JJ (ed) Methods of behavior analysis in neuroscience, 2nd edn. CRC Press\/Taylor & Francis, Boca Raton (FL)","edition":"2"},{"key":"6946_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109971","volume":"253","author":"M Rae","year":"2024","unstructured":"Rae M, Gomes I, Spelta LEW et al (2024) Environmental enrichment enhances ethanol preference over social reward in male Swiss mice: involvement of oxytocin-dopamine interactions. Neuropharmacology 253:109971. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109971","journal-title":"Neuropharmacology"},{"key":"6946_CR44","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s00213-020-05609-6","volume":"237","author":"HS Reis","year":"2020","unstructured":"Reis HS, Rodrigues IRS, Anjos-Santos A et al (2020) Ayahuasca blocks the reinstatement of methylphenidate-induced conditioned place preference in mice: behavioral and brain Fos expression evaluations. Psychopharmacology 237:3269\u20133281. https:\/\/doi.org\/10.1007\/s00213-020-05609-6","journal-title":"Psychopharmacology"},{"key":"6946_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1124\/jpet.103.049882","volume":"306","author":"J Riba","year":"2003","unstructured":"Riba J, Valle M, Urbano G (2003) Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther 306:73\u201383. https:\/\/doi.org\/10.1124\/jpet.103.049882","journal-title":"J Pharmacol Exp Ther"},{"key":"6946_CR46","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.1021\/acsomega.2c00795","volume":"7","author":"L Rodr\u00edguez","year":"2022","unstructured":"Rodr\u00edguez L, L\u00f3pez A, Moyna G (2022) New insights into the chemical composition of Ayahuasca. ACS Omega 7:12307\u201312317. https:\/\/doi.org\/10.1021\/acsomega.2c00795","journal-title":"ACS Omega"},{"key":"6946_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","volume":"36","author":"RF Sanches","year":"2016","unstructured":"Sanches RF, de Lima Os\u00f3rio F, Dos Santos RG et al (2016) Antidepressant effects of a single dose of Ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol 36:77\u201381. https:\/\/doi.org\/10.1097\/JCP.0000000000000436","journal-title":"J Clin Psychopharmacol"},{"key":"6946_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/15733998113099990003","volume":"6","author":"G Thomas","year":"2013","unstructured":"Thomas G, Lucas P, Capler NR et al (2013) Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev 6:30\u201342. https:\/\/doi.org\/10.2174\/15733998113099990003","journal-title":"Curr Drug Abuse Rev"},{"issue":"6","key":"6946_CR49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0301-0082(98)00060-4","volume":"56","author":"TM Tzschentke","year":"1998","unstructured":"Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56(6):613\u2013672. https:\/\/doi.org\/10.1016\/S0301-0082(98)00060-4","journal-title":"Prog Neurobiol"},{"key":"6946_CR50","volume-title":"World drug report 2025 \u2013 Special points of interest","author":"UNODC","year":"2025","unstructured":"UNODC (2025) World drug report 2025 \u2013 Special points of interest. UNODC, Vienna"},{"key":"6946_CR51","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/cns.14054","volume":"29","author":"J Wang","year":"2023","unstructured":"Wang J, Liang M, Shang Q et al (2023) Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R \u2010mediated ERK signaling. CNS Neurosci Ther 29:831\u2013841. https:\/\/doi.org\/10.1111\/cns.14054","journal-title":"CNS Neurosci Ther"},{"key":"6946_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2023.1256764","volume":"17","author":"JR Yates","year":"2023","unstructured":"Yates JR (2023) Quantifying conditioned place preference: a review of current analyses and a proposal for a novel approach. Front Behav Neurosci 17:1256764. https:\/\/doi.org\/10.3389\/fnbeh.2023.1256764","journal-title":"Front Behav Neurosci"},{"key":"6946_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2024.102898","volume":"87","author":"EJ Young","year":"2024","unstructured":"Young EJ, Radnai L, Prikhodko V, Miller CA (2024) Novel therapeutics in development for the treatment of stimulant-use disorder. Curr Opin Neurobiol 87:102898. https:\/\/doi.org\/10.1016\/j.conb.2024.102898","journal-title":"Curr Opin Neurobiol"},{"key":"6946_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00225","volume":"6","author":"G Zhang","year":"2015","unstructured":"Zhang G, Stackman RW (2015) The role of serotonin 5-HT2A receptors in memory and cognition. Front Pharmacol 6:225. https:\/\/doi.org\/10.3389\/fphar.2015.00225","journal-title":"Front Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06946-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:01:13Z","timestamp":1761879673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-025-06946-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":54,"alternative-id":["6946"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06946-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}